Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of Treatment for Panic Disorder

This study has been completed.
Sponsor:
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00456768
First received: April 3, 2007
Last updated: April 28, 2011
Last verified: April 2011
  Purpose

The purpose of these questionnaires is to give us an overview of how panic has affected your life and perhaps also to give us some clues about things that may have set you up to experience panic.


Condition
Panic Disorder

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Efficacy of Treatment for Panic Disorder

Resource links provided by NLM:


Further study details as provided by University of British Columbia:

Estimated Enrollment: 250
Study Start Date: May 2003
Study Completion Date: April 2011
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Detailed Description:

For us to evaluate the efficacy of our treatment programs, we are interested in your responses before and after treatment. We use two methods to evaluate the efficacy of our treatments: questionnaires and interviews with a member of the Anxiety Disorders Clinic. As part of standard clinic procedure, each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment. If you have received this questionnaire packet, it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic. The purpose of the questionnaire packet is to assess the severity of your panic disorder; its impact on your functioning, and factors that may contribute to the onset or maintenance of your panic (e.g., depression, anxiety sensitivity). We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic.

  Eligibility

Ages Eligible for Study:   19 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients referred to the Anxiety Disorders Clinic, Vancouver, who receive a primary diagnosis of Panic Disorder, and are accepted for treatment at the clinic.

Criteria

Inclusion Criteria:

  • Patients referred to the Anxiety Disorders Clinic who receive a primary diagnosis of Panic Disorder, and are accepted for treatment at the clinic.

Exclusion Criteria:

  • Individuals who either have not sought treatment for anxiety at the Anxiety Disorders Clinic or patients who did not receive a primary diagnosis of Panic Disorder.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00456768

Locations
Canada, British Columbia
Anxiety Disorders Clinic, University of British Columbia
Vancouver, British Columbia, Canada, V6T 1Z9
Sponsors and Collaborators
University of British Columbia
Investigators
Principal Investigator: Maureen Whittal, Ph.D University of British Columbia
  More Information

No publications provided

Responsible Party: Dr. Maureen Whittal, University of British Columbia
ClinicalTrials.gov Identifier: NCT00456768     History of Changes
Other Study ID Numbers: H03-80265
Study First Received: April 3, 2007
Last Updated: April 28, 2011
Health Authority: Canada: Health Canada

Keywords provided by University of British Columbia:
Panic Disorder
Anxiety
Treatment efficacy

Additional relevant MeSH terms:
Disease
Panic Disorder
Anxiety Disorders
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on November 20, 2014